Announcements Trials
Browse Landscape

Phase

Phase 2 3Phase NA 1Phase 4 1

Status

Unknown 6Completed 5Active not recruiting 5Recruiting 2Not yet recruiting 2Withdrawn 1Enrolling by invitation 1

Sponsor Class

OTHER 4INDUSTRY 1

Study Type

Interventional 5

Sponsor

Cancer Type

Lymphoid 5

Conditions

Lymphoma, Large B-Cell, Diffuse 5Lymphoma, Mantle-Cell 2Lymphoma, Non-Hodgkin 1Lymphoma 1HIV Infections 1

Interventions

Rituximab 187Cyclophosphamide 174Etoposide 94Peripheral Blood Stem Cell Transplantation 90Vincristine 89Prednisone 80Doxorubicin 79Filgrastim 75fludarabine phosphate 60Radiotherapy 56Mycophenolic Acid 41Melphalan 41Cytarabine 41Busulfan 40Cyclosporine 39Methotrexate 37Whole-Body Irradiation 36Tacrolimus 35Carmustine 34Ifosfamide 28Lenalidomide 27Granulocyte Colony-Stimulating Factor 27Antilymphocyte Serum 27Gemcitabine 25Carboplatin 25Methylprednisolone 24ibritumomab tiuxetan 23Bortezomib 22Dexamethasone 21ibrutinib 18

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

5 trials
RecentStart dateEnrollment
Completed × Lymphoma, Large B-Cell, Diffuse × R-CHOP protocol × Clear all
NCT00268853 2024-05-30

RAPID

CTI BioPharma

Phase 2 Completed
124 enrolled 13 charts
Lymphoid

Lymphoma, Lymphoma, Large B-Cell, Diffuse

NCT02660710 2022-10-28

Rituximab Plus CHOP Chemotherapy for Diffuse Large B-cell Lymphoma

UNC Lineberger Comprehensive Cancer Center

Phase 2 Completed
39 enrolled
Lymphoid

Lymphoma, Large B-Cell, Diffuse

NCT02890602 2020-02-20

Erythropoietin for Management of Anemia Caused by Chemotherapy

Kosin University Gospel Hospital

Phase 2 Completed
53 enrolled
Lymphoid

Lymphoma, Large B-Cell, Diffuse

NCT00530179 2019-01-22

PET-Chop

AHS Cancer Control Alberta

Phase NA Completed
69 enrolled
Lymphoid

Lymphoma, Large B-Cell, Diffuse

NCT00466258 2009-11-25

LINFOTARGAM

PETHEMA Foundation

Phase 4 Completed
50 enrolled
Lymphoid

HIV Infections, Lymphoma, Large B-Cell, Diffuse

Data powered by HemOnc (CC BY 4.0) Colophon âš¡